Fairmount Partners January 2020 News

Fairmount is one of the largest and most active M&A firms based in the Mid-Atlantic, with a national and international practice. Since 2003, the firm has completed more than 220 transactions throughout North and South America, Europe, Asia and Australia. Fairmount specializes in advising middle-market companies on sell-side, buy-side and capital placement transactions, and provides fairness opinions and strategic advice in the transaction context.

  • Fairmount Partners advised California-based THREAD Research in its sale to Water Street Healthcare Partners and JLL Partners. THREAD is an innovative provider of technology that enables virtual research approaches to modernize clinical studies and registries. THREAD’s platform and services are designed to make clinical trials and registries more accessible and less costly by replacing patient visits at investigator sites with technology-enabled interactions at more convenient locations, including patients’ homes. Water Street and JLL Partners, two of the most active private equity investors in the pharmaceutical services sector, will invest their combined industry experience and network of resources to further develop and expand THREAD’s offering on a global scale.
  • Fairmount Partners represented Haskell Office, LLC, a leading provider of innovative furniture solutions, in the completion of a debt recapitalization transaction with The PNC Financial Services Group, Inc. (“PNC”). Since its founding in 1947, Haskell has earned a global reputation for excellence by supplying superior quality furniture to its customers. Haskell has been supported by PNC since 2002 for its commercial banking needs, and as the Company has continued to scale (i.e., revenue, profitability, product portfolio, customer base), PNC has continued to expand its lending partnership with Haskell.
  • Fairmount assisted Philadelphia-based GSI Health, a SaaS provider of workflow, engagement and compliance solutions and related services, in its sale to Medecision, an integrated health management solutions provider. GSI Health has been an innovator in driving change in the industry since 2003, having pioneered workflow automation and system integration with community care providers to streamline care coordination and value-based payments for population health improvements. The GSI Health population health platform, GSIHealthCoordinator, will become part of Medecision’s Aerial™ solution, a HITRUST CSF®-certified SaaS solution that optimizes the delivery of decision support to care teams and family members.
  • Fairmount Partners advised Boston-based Cambridge Biomedical, a leading large molecule-focused bioanalytical and biomarker lab, in its sale to BioAgilytix. The transaction expands BioAgilytix’s global footprint into the heart of the world’s major biotech center, and adds further capacity by joining Cambridge Biomedical’s CLIA-certified, CAP-credited, and GLP-compliant facility with its GxP laboratories in Durham, North Carolina and Hamburg, Germany. Cambridge Biomedical has particularly extensive capabilities in kit production as well as a premier molecular suite equipped with the latest generation of PCR platforms, both of which will be immediately available to BioAgilytix’s customers.